Skip to main content
Journal cover image

WHICH PATIENTS NEED AROMATASE INHIBITORS DURING OVARIAN STIMULATION FOR FERTILITY PRESERVATION? ER-ALPHA EXPRESSION AS A SURROGATE FOR ESTROGEN RESPONSIVENESS

Publication ,  Conference
Acharya, CR; Friedlander, HS; Price, TM; Acharya, KS
Published in: FERTILITY AND STERILITY
2023

Duke Scholars

Published In

FERTILITY AND STERILITY

EISSN

1556-5653

ISSN

0015-0282

Publication Date

2023

Volume

120

Issue

4

Start / End Page

E116 / E116

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • 3215 Reproductive medicine
  • 1117 Public Health and Health Services
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Acharya, C. R., Friedlander, H. S., Price, T. M., & Acharya, K. S. (2023). WHICH PATIENTS NEED AROMATASE INHIBITORS DURING OVARIAN STIMULATION FOR FERTILITY PRESERVATION? ER-ALPHA EXPRESSION AS A SURROGATE FOR ESTROGEN RESPONSIVENESS. In FERTILITY AND STERILITY (Vol. 120, pp. E116–E116).
Acharya, Chaitanya R., Hilary S. Friedlander, Thomas M. Price, and Kelly S. Acharya. “WHICH PATIENTS NEED AROMATASE INHIBITORS DURING OVARIAN STIMULATION FOR FERTILITY PRESERVATION? ER-ALPHA EXPRESSION AS A SURROGATE FOR ESTROGEN RESPONSIVENESS.” In FERTILITY AND STERILITY, 120:E116–E116, 2023.
Journal cover image

Published In

FERTILITY AND STERILITY

EISSN

1556-5653

ISSN

0015-0282

Publication Date

2023

Volume

120

Issue

4

Start / End Page

E116 / E116

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • 3215 Reproductive medicine
  • 1117 Public Health and Health Services
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences